Tolerance.ca
Director / Editor: Victor Teboul, Ph.D.
Looking inside ourselves and out at the world
Independent and neutral with regard to all political and religious orientations, Tolerance.ca® aims to promote awareness of the major democratic principles on which tolerance is based.

FDA drug approval affects healthcare around the world, but political shortcuts could hurt the agency’s international reputation

By C. Michael White, Distinguished Professor of Pharmacy Practice, University of Connecticut
At the beginning of July 2026, the U.S. Food and Drug Administration approved the first gene therapy for young children with sickle cell disease.

While this is good news for children in the U.S. born with this illness, the FDA’s approval may also benefit


Read complete article

© The Conversation -
Subscribe to Tolerance.ca


Follow us on ...
Facebook Twitter